The costs associated with discovery, and particularly electronic document discovery, in patent litigation can be effectively controlled with upfront planning, preparation, and coordination between inhouse and outside...more
In This Issue:
Federal Courts Debate Safe Harbor Exemption for Patent Infringement Under 35 U.S.C. § 271(e) Following Merck v. Integra; If I Prioritize Examination of My Application, Should the Patent Office?;...more
2/19/2013
/ Biotechnology ,
Discovery ,
Exemptions ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Infringement ,
Integra ,
InterDigital Communications v ITC ,
Merck ,
Non-Practicing Entities ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Prioritized Examination ,
Safe Harbors
The costs associated with discovery, and particularly electronic document discovery, in patent litigation can be effectively controlled with upfront planning, preparation, and coordination between in-house and outside...more